8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001558370-16-008293
Material agreement · Delisting notice · Executive or director change · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 3.01 Notice of delisting or failure to meet a listing standard
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading cerc-20160912x8k.htm…